Association between statin usage and prostate cancer prevention: a refined meta-analysis based on literature from the years 2005-2010.
BACKGROUND
Statins are cholesterol-lowering drugs that are widely used to prevent and treat atherosclerotic cardiovascular disease. It was found that statins can be associated with the occurrence of prostate cancer. However, no consensus has been concluded.


METHODS
In the present study, we provide a refined meta-analysis on the association between statins and prostate cancers. Our objective is to offer a congruent recognition of the impact of statins on prostate cancer.


RESULTS
Our refined analysis has included seven previous publications from the years 2005 to 2010.


CONCLUSIONS
Based on the results, we concluded that there were associations for statin usage in preventing prostate cancer (OR 1.195, 95% CI 1.018-1.403, p = 0.029). Different from previous meta-analyses, our positive conclusion is primarily based on the recent new published literature, which supported the efficiency of statin use to control prostate cancer. More specific efforts for excluding the influence of other factors are crucial in further assessment of the efficiency of statin use.
Department of Urology, General Hospital of Beijing Military Command, Beijing, China. hnandbjzy@gmail.com
Yong
Y
Zhang
Tong
T
Zang
D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D015994:Incidence; D016014:Linear Models; D008297:Male; D016017:Odds Ratio; D011471:Prostatic Neoplasms / Q000453:epidemiology / Q000517:prevention & control*; D013997:Time Factors
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors